Myeloma Paper of the Day, June 15th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Natural killer cells with adhesion defects and reduced cytotoxic functions (CD16/CD226-low) are associated with a shorter overall survival in myeloma.”
Source: Robert Orlowski/X
Authors: Eve Blanquart, Rüçhan Ekren, Bineta Rigaud, Marie Veronique Joubert, virginie Baylot, Hélène Daunes, Marine Cuisinier, Marine Villard, Nadège Carrié, Celine Mazzotti, Liliana E Lucca, Aurore Perrot, Jill Corre, Thierry Walzer, Hervé Avet-Loiseau, Pierre-Paul Axisa, Ludovic Martinet.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
